Not sure whether this is positive for OPT.
Fundamentally we're all in this for one of the owners of either Lucentis or Eylea to buy/partner with OPT. With Beovu struggling to gain traction, it takes some pressure off Lucentis and Eylea. That pressure, combined with imminent patent expiry, are what will drive M&A. I'm not saying that Beovu struggling removes the rationale for buying OPT, but it might decrease the urgency somewhat
Not sure whether this is positive for OPT.Fundamentally we're...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.010(2.78%) |
Mkt cap ! $382.0M | |||
| Open | High | Low | Value | Volume |
| 35.5¢ | 36.5¢ | 35.0¢ | $934.4K | 2.624M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 230715 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 17816 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| OPT (ASX) Chart |